Leptin alters energy intake and fat mass but not energy expenditure in lean subjects
Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in...
Saved in:
Published in | Nature communications Vol. 11; no. 1; pp. 5145 - 15 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
13.10.2020
Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.
Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure. |
---|---|
AbstractList | Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.
Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure. Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass. Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass.Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not respond to leptin treatment, suggesting the presence of leptin tolerance and questioning the role of leptin as regulator of energy balance in humans. We thus performed detailed novel measurements and analyses of samples and data from our clinical trials biobank to investigate leptin effects on mechanisms of weight regulation in lean normo- and mildly hypo-leptinemic individuals without genetic disorders. We demonstrate that short-term leptin administration alters food intake during refeeding after fasting, whereas long-term leptin treatment reduces fat mass and body weight, and transiently alters circulating free fatty acids in lean mildly hypoleptinemic individuals. Leptin levels before treatment initiation and leptin dose do not predict the observed weight loss in lean individuals suggesting a saturable effect of leptin. In contrast to data from animal studies, leptin treatment does not affect energy expenditure, lipid utilization, SNS activity, heart rate, blood pressure or lean body mass. Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin therapy. Here the authors report a retrospective analysis of four clinical trials in normo- and mildly hypoleptinemic individuals and show that leptin therapy alters food intake in the short term and reduces weight and fat mass in the long term without effects on energy expenditure. |
ArticleNumber | 5145 |
Author | Peradze, Natia Farr, Olivia M. Sala-Vila, Aleix Chrysafi, Pavlina Perakakis, Nikolaos Stefanakis, Konstantinos Mantzoros, Christos S. |
Author_xml | – sequence: 1 givenname: Pavlina surname: Chrysafi fullname: Chrysafi, Pavlina organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School – sequence: 2 givenname: Nikolaos orcidid: 0000-0002-2319-6603 surname: Perakakis fullname: Perakakis, Nikolaos organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School – sequence: 3 givenname: Olivia M. surname: Farr fullname: Farr, Olivia M. organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School – sequence: 4 givenname: Konstantinos surname: Stefanakis fullname: Stefanakis, Konstantinos organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School – sequence: 5 givenname: Natia surname: Peradze fullname: Peradze, Natia organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School – sequence: 6 givenname: Aleix surname: Sala-Vila fullname: Sala-Vila, Aleix organization: Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) – sequence: 7 givenname: Christos S. orcidid: 0000-0003-3755-8158 surname: Mantzoros fullname: Mantzoros, Christos S. email: cmantzor@bidmc.harvard.edu organization: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School |
BookMark | eNp9kctuFDEQRS0URELID7Dykk0TP8f2BglFPCKNxCasreru8uChxx5sNyJ_n55MggiLeGOrfO-pKt3X5CTlhIS85ew9Z9JeVsXVynRMsI5ba3XnXpAzwRTvuBHy5J_3KbmodcuWIx23Sr0ip1IyzZV2Z-RmjfsWE4WpYakUE5bNLY2pwU-kkEYaoNEd1Er7udGU26ME_-wxjbHNBRc5nRASrXO_xaHVN-RlgKnixcN9Tr5__nRz9bVbf_tyffVx3Q3KutZprk0YV0pwE6xzEPQIJjgTtLYjaKVlL3uhhNF6cGGFZhQhMA4gUQpmnTwn10fumGHr9yXuoNz6DNHfF3LZeCgtDhN6q_gCNUr0A1cSjHVs1AqZDAK5BLuwPhxZ-7nf4ThgagWmJ9CnPyn-8Jv82y_TSSfEAnj3ACj514y1-V2sA04TJMxz9UJpziUX7iAVR-lQcq0Fw982nPlDuv6Yrl_S9ffp-sOy9j_TEBu0mA_jxOl5qzxa69InbbD4bZ5LWqJ5znUHWq252Q |
CitedBy_id | crossref_primary_10_3390_metabo14040221 crossref_primary_10_1080_08820139_2022_2129381 crossref_primary_10_1080_10641963_2022_2071920 crossref_primary_10_1590_s0004_2803_202302022_96 crossref_primary_10_1186_s40795_022_00531_w crossref_primary_10_3390_ijms21249368 crossref_primary_10_3390_antiox13121485 crossref_primary_10_35378_gujs_1422409 crossref_primary_10_1016_j_cmet_2023_02_008 crossref_primary_10_1210_clinem_dgab517 crossref_primary_10_1016_j_clnu_2025_01_014 crossref_primary_10_1016_j_neubiorev_2022_104807 crossref_primary_10_1084_jem_20191593 crossref_primary_10_3389_fimmu_2024_1481312 crossref_primary_10_3389_fnut_2022_1002619 crossref_primary_10_1249_MSS_0000000000003518 crossref_primary_10_3390_cells12030407 crossref_primary_10_1016_j_metabol_2022_155265 crossref_primary_10_1016_j_metabol_2024_155984 crossref_primary_10_1021_acsptsci_3c00301 crossref_primary_10_1111_liv_15847 crossref_primary_10_1016_j_metabol_2023_155689 crossref_primary_10_1210_clinem_dgab269 crossref_primary_10_1515_hmbci_2022_0020 crossref_primary_10_1007_s11248_021_00288_1 crossref_primary_10_1038_s41366_021_00972_6 crossref_primary_10_1210_endrev_bnac015 crossref_primary_10_1016_j_molmet_2024_102078 crossref_primary_10_1210_clinem_dgab782 crossref_primary_10_1016_j_crbiot_2024_100204 crossref_primary_10_1038_s41467_024_49366_y crossref_primary_10_3390_ijms23073965 crossref_primary_10_3390_biom13060972 crossref_primary_10_1016_j_neubiorev_2023_105164 crossref_primary_10_1016_j_jacc_2020_11_069 crossref_primary_10_1093_psyrad_kkad023 crossref_primary_10_1016_j_foodres_2023_112550 crossref_primary_10_1038_s41598_021_98605_5 crossref_primary_10_1007_s11154_021_09687_5 crossref_primary_10_3389_fnut_2022_809865 crossref_primary_10_3390_nu13041216 crossref_primary_10_1210_endrev_bnab034 crossref_primary_10_1002_prp2_70027 crossref_primary_10_1111_dom_16194 crossref_primary_10_1186_s10020_023_00702_w crossref_primary_10_1177_09731296231198316 crossref_primary_10_1016_j_metabol_2024_156053 crossref_primary_10_1159_000527386 crossref_primary_10_1038_s41390_023_02632_z crossref_primary_10_1111_brv_13039 crossref_primary_10_1016_j_pharmthera_2022_108284 crossref_primary_10_3390_biom13030470 crossref_primary_10_1016_j_metabol_2024_156056 crossref_primary_10_1186_s12929_022_00796_0 crossref_primary_10_3389_fpsyg_2022_885274 crossref_primary_10_1210_endrev_bnae011 crossref_primary_10_1080_1028415X_2022_2161135 crossref_primary_10_1007_s00787_021_01778_7 crossref_primary_10_22141_2224_0721_18_8_2022_1220 crossref_primary_10_1165_rcmb_2021_0199ED |
Cites_doi | 10.1161/CIRCGENETICS.114.000216 10.1056/NEJMoa040388 10.1172/JCI200317490 10.1038/s41591-019-0370-1 10.1007/s11306-007-0082-2 10.1126/science.7624776 10.1210/jendso/bvz022 10.1038/s41467-019-13721-1 10.1210/jcem.85.11.6955 10.1038/msb.2010.93 10.1249/MSS.0b013e31821ece12 10.1038/s41591-019-0722-x 10.1111/j.1463-1326.2005.00468.x 10.1007/BF00585195 10.1001/jama.282.16.1568 10.2337/diabetes.48.9.1787 10.1039/b910205a 10.1172/JCI0215693 10.1152/ajpregu.00045.2016 10.1038/sj.ijo.0802431 10.1210/jc.2012-3009 10.1016/j.cyto.2018.10.012 10.1038/s41467-019-12703-7 10.1038/s42255-019-0095-y 10.1016/j.ecl.2012.04.017 10.1038/s41467-019-11311-9 10.1161/01.HYP.37.3.936 10.1172/JCI25977 10.1038/382250a0 10.1038/s41467-019-13770-6 10.1016/j.cell.2017.12.001 10.1210/jc.2005-1545 10.1111/j.1749-6632.2002.tb04517.x 10.1093/ajcn/74.4.426 10.1038/s41467-019-13870-3 10.1038/sj.mp.4000418 10.1530/EJE-11-0252 10.2337/db10-1791 10.1073/pnas.0505429103 10.1172/JCI122042 10.2337/db15-1550 10.1073/pnas.0903723106 10.1016/j.cell.2015.08.055 10.1093/bioinformatics/bty528 10.1073/pnas.94.16.8878 10.1038/sj.ijo.0801952 10.1152/ajpendo.00546.2010 10.1001/jama.1992.03490120092034 10.2165/00003088-200847110-00006 10.1126/science.7624777 10.1038/s41598-017-16135-5 10.3945/ajcn.111.012385 10.1200/JCO.1999.17.10.3291 10.1007/s12020-018-1589-1 10.1038/ncomms11122 10.1056/NEJM199602013340503 10.1016/j.jacc.2017.12.006 10.2337/db18-296-LB 10.2337/db10-1302 10.1172/jci.insight.121434 10.1007/s12020-019-01862-8 10.1038/nm1295-1311 10.1056/NEJMoa012437 10.1002/oby.20433 10.1016/j.atherosclerosis.2020.03.028 10.1038/srep11189 10.1016/j.cmet.2017.05.013 10.1073/pnas.1015674108 10.1038/43448 10.1210/jc.2014-2774 10.1101/2020.07.02.20143685 10.1111/j.1365-2265.2006.02684.x 10.1016/S0022-2275(20)41345-8 10.1210/clinem/dgaa251 |
ContentType | Journal Article |
Copyright | This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020 |
Copyright_xml | – notice: This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2020 |
DBID | C6C AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1038/s41467-020-18885-9 |
DatabaseName | Springer Nature OA Free Journals CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 15 |
ExternalDocumentID | oai_doaj_org_article_84158d742bc143a7890d54e03f2e13a8 PMC7553922 10_1038_s41467_020_18885_9 |
GrantInformation_xml | – fundername: The current study was funded by NIH K24DK081913. Ni.P. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) –389891681 (PE 2431/2-1). A.S.-V. is recipient of the Instituto de Salud Carlos III Miguel Servet fellowship (grant CP II 17/00029). P.C. received a 2018 Summer Research Fellowship (SRF) funded by the Endocrine Society to support participation in the research project. – fundername: ; |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AASML AAYXX CITATION PHGZM PHGZT 7X8 AARCD PJZUB PPXIY PQGLB 5PM PUEGO |
ID | FETCH-LOGICAL-c489t-5157fd64217f899af5da7f97f558da5453b3b242755c9f6e7d2ff01aa3e320893 |
IEDL.DBID | M48 |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:27:29 EDT 2025 Thu Aug 21 14:10:25 EDT 2025 Tue Aug 05 11:38:54 EDT 2025 Tue Jul 01 04:09:05 EDT 2025 Thu Apr 24 23:03:38 EDT 2025 Fri Feb 21 02:40:07 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c489t-5157fd64217f899af5da7f97f558da5453b3b242755c9f6e7d2ff01aa3e320893 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-2319-6603 0000-0003-3755-8158 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-020-18885-9 |
PMID | 33051459 |
PQID | 2451131292 |
PQPubID | 23479 |
PageCount | 15 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_84158d742bc143a7890d54e03f2e13a8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7553922 proquest_miscellaneous_2451131292 crossref_primary_10_1038_s41467_020_18885_9 crossref_citationtrail_10_1038_s41467_020_18885_9 springer_journals_10_1038_s41467_020_18885_9 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-10-13 |
PublicationDateYYYYMMDD | 2020-10-13 |
PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-13 day: 13 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationYear | 2020 |
Publisher | Nature Publishing Group UK Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Portfolio |
References | Satoh (CR43) 1999; 48 Wurtz, Soininen (CR75) 2020; 302 Heymsfield (CR14) 1999; 282 Mittendorfer (CR15) 2011; 60 Kaklamani (CR54) 1999; 17 Zelissen (CR21) 2005; 7 Steinhauser (CR34) 2018; 3 Zuber, Colijn, Klaver, Burgess (CR68) 2020; 11 Hukshorn (CR20) 2002; 26 Holmes (CR74) 2018; 71 Wu (CR4) 2010; 39 Mackowiak, Wasserman, Levine (CR32) 1992; 268 Korner (CR45) 2013; 21 CR77 Hukshorn (CR19) 2000; 85 Perry (CR35) 2018; 172 Inouye (CR67) 2010; 6 Correia, Morgan, Sivitz, Mark, Haynes (CR40) 2001; 37 Chan, Heist, DePaoli, Veldhuis, Mantzoros (CR26) 2003; 111 Gallois (CR71) 2019; 10 Halaas (CR6) 1995; 269 Westerterp-Plantenga, Saris, Hukshorn, Campfield (CR60) 2001; 74 Oral (CR31) 2002; 346 Friedman (CR25) 2019; 1 Farr (CR59) 2014; 99 Chong, Xia (CR79) 2018; 34 Sumner (CR64) 2007; 3 Soininen (CR66) 2009; 134 Shibuya (CR44) 2002; 971 Kettunen (CR73) 2016; 7 Clemmons (CR53) 2012; 41 Ahima (CR49) 1996; 382 Kissileff (CR46) 2012; 95 Vojinovic (CR70) 2019; 10 Chan (CR27) 2006; 103 Chan, Wong, Mantzoros (CR30) 2008; 47 Deelen (CR72) 2019; 10 Rosenbaum, Sy, Pavlovich, Leibel, Hirsch (CR48) 2008; 118 Halaas (CR9) 1997; 94 Pandit, Beerens, Adan (CR39) 2017; 312 DePaoli, Long, Fine, Stewart, O’Rahilly (CR23) 2018; 67 Hagenbeek (CR69) 2020; 11 Kirsten (CR55) 1977; 368 Lee, Chan, Sourlas, Raptopoulos, Mantzoros (CR12) 2006; 91 Moon (CR16) 2011; 60 Schlogl (CR58) 2016; 65 Lejeune, Hukshorn, Saris, Westerterp-Plantenga (CR22) 2003; 27 Zeng (CR8) 2015; 163 Machleidt (CR41) 2013; 98 Frederich (CR1) 1995; 1 Fogteloo, Pijl, Frolich, McCamish, Meinders (CR18) 2003; 16 Audi (CR5) 1998; 3 Chan, Mietus, Raciti, Goldberger, Mantzoros (CR62) 2007; 66 CR51 Singh (CR7) 2009; 106 Grewal (CR52) 2020; 4 Pelleymounter (CR37) 1995; 269 Boden, Chen, Mozzoli, Ryan (CR3) 1996; 81 Shimomura, Hammer, Ikemoto, Brown, Goldstein (CR56) 1999; 401 Rosenbaum (CR47) 2005; 115 Tang, Tang, Li, Wang (CR38) 2015; 5 Flier, Maratos-Flier (CR24) 2017; 26 Soininen, Kangas, Wurtz, Suna, Ala-Korpela (CR65) 2015; 8 Hwa (CR50) 1997; 272 Puschel (CR57) 2019; 113 Oral (CR13) 2019; 64 Agren, Julkunen, Penttila (CR78) 1992; 33 Liu (CR76) 2020; 26 Shetty (CR17) 2011; 165 Chou (CR28) 2011; 108 Ainsworth (CR63) 2011; 43 Welt (CR29) 2004; 351 Considine (CR2) 1996; 334 Gilgen-Ammann (CR33) 2017; 7 Rosenbaum, Leibel (CR36) 2018; 128 Morton (CR42) 2011; 300 Brown (CR10) 2018; 60 Farooqi (CR11) 2002; 110 Dallner (CR61) 2019; 25 ML Correia (18885_CR40) 2001; 37 F Machleidt (18885_CR41) 2013; 98 J Liu (18885_CR76) 2020; 26 HS Moon (18885_CR16) 2011; 60 M Rosenbaum (18885_CR48) 2008; 118 JH Lee (18885_CR12) 2006; 91 MA Pelleymounter (18885_CR37) 1995; 269 OS Dallner (18885_CR61) 2019; 25 M Inouye (18885_CR67) 2010; 6 GJ Morton (18885_CR42) 2011; 300 EA Oral (18885_CR31) 2002; 346 RJ Brown (18885_CR10) 2018; 60 JL Halaas (18885_CR6) 1995; 269 B Wu (18885_CR4) 2010; 39 I Shibuya (18885_CR44) 2002; 971 J Chong (18885_CR79) 2018; 34 CK Welt (18885_CR29) 2004; 351 M Rosenbaum (18885_CR36) 2018; 128 JJ Hwa (18885_CR50) 1997; 272 G Boden (18885_CR3) 1996; 81 LW Sumner (18885_CR64) 2007; 3 L Audi (18885_CR5) 1998; 3 JL Chan (18885_CR30) 2008; 47 J Kettunen (18885_CR73) 2016; 7 JL Chan (18885_CR26) 2003; 111 J Puschel (18885_CR57) 2019; 113 EA Oral (18885_CR13) 2019; 64 AJ Fogteloo (18885_CR18) 2003; 16 JS Flier (18885_CR24) 2017; 26 ML Steinhauser (18885_CR34) 2018; 3 V Zuber (18885_CR68) 2020; 11 P Soininen (18885_CR66) 2009; 134 RJ Perry (18885_CR35) 2018; 172 PM Zelissen (18885_CR21) 2005; 7 MV Holmes (18885_CR74) 2018; 71 A Singh (18885_CR7) 2009; 106 A Gallois (18885_CR71) 2019; 10 J Deelen (18885_CR72) 2019; 10 P Wurtz (18885_CR75) 2020; 302 GK Shetty (18885_CR17) 2011; 165 R Pandit (18885_CR39) 2017; 312 RV Considine (18885_CR2) 1996; 334 CJ Hukshorn (18885_CR20) 2002; 26 18885_CR51 JL Chan (18885_CR27) 2006; 103 FA Hagenbeek (18885_CR69) 2020; 11 VG Kaklamani (18885_CR54) 1999; 17 D Vojinovic (18885_CR70) 2019; 10 JJ Agren (18885_CR78) 1992; 33 GB Tang (18885_CR38) 2015; 5 MS Westerterp-Plantenga (18885_CR60) 2001; 74 JL Halaas (18885_CR9) 1997; 94 RC Frederich (18885_CR1) 1995; 1 JM Friedman (18885_CR25) 2019; 1 A DePaoli (18885_CR23) 2018; 67 CJ Hukshorn (18885_CR19) 2000; 85 B Mittendorfer (18885_CR15) 2011; 60 H Schlogl (18885_CR58) 2016; 65 J Korner (18885_CR45) 2013; 21 W Zeng (18885_CR8) 2015; 163 BE Ainsworth (18885_CR63) 2011; 43 N Satoh (18885_CR43) 1999; 48 DR Clemmons (18885_CR53) 2012; 41 I Shimomura (18885_CR56) 1999; 401 18885_CR77 SB Heymsfield (18885_CR14) 1999; 282 PA Mackowiak (18885_CR32) 1992; 268 JL Chan (18885_CR62) 2007; 66 P Soininen (18885_CR65) 2015; 8 RS Ahima (18885_CR49) 1996; 382 M Rosenbaum (18885_CR47) 2005; 115 SH Chou (18885_CR28) 2011; 108 IS Farooqi (18885_CR11) 2002; 110 HR Kissileff (18885_CR46) 2012; 95 S Grewal (18885_CR52) 2020; 4 OM Farr (18885_CR59) 2014; 99 MP Lejeune (18885_CR22) 2003; 27 R Kirsten (18885_CR55) 1977; 368 R Gilgen-Ammann (18885_CR33) 2017; 7 |
References_xml | – volume: 8 start-page: 192 year: 2015 end-page: 206 ident: CR65 article-title: Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics publication-title: Circ. Cardiovasc. Genet. doi: 10.1161/CIRCGENETICS.114.000216 – volume: 351 start-page: 987 year: 2004 end-page: 997 ident: CR29 article-title: Recombinant human leptin in women with hypothalamic amenorrhea publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa040388 – volume: 111 start-page: 1409 year: 2003 end-page: 1421 ident: CR26 article-title: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men publication-title: J. Clin. Investig. doi: 10.1172/JCI200317490 – volume: 25 start-page: 507 year: 2019 end-page: 516 ident: CR61 article-title: Dysregulation of a long noncoding RNA reduces leptin leading to a leptin-responsive form of obesity publication-title: Nat. Med. doi: 10.1038/s41591-019-0370-1 – volume: 3 start-page: 211 year: 2007 end-page: 221 ident: CR64 article-title: Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI) publication-title: Metabolomics doi: 10.1007/s11306-007-0082-2 – volume: 269 start-page: 540 year: 1995 end-page: 543 ident: CR37 article-title: Effects of the obese gene product on body weight regulation in ob/ob mice publication-title: Science doi: 10.1126/science.7624776 – volume: 4 start-page: bvz022 year: 2020 ident: CR52 article-title: Metabolomic analysis of the effects of leptin replacement therapy in patients with lipodystrophy publication-title: J. Endocr. Soc. doi: 10.1210/jendso/bvz022 – ident: CR51 – volume: 10 year: 2019 ident: CR70 article-title: Relationship between gut microbiota and circulating metabolites in population-based cohorts publication-title: Nat. Commun. doi: 10.1038/s41467-019-13721-1 – volume: 85 start-page: 4003 year: 2000 end-page: 4009 ident: CR19 article-title: Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.85.11.6955 – volume: 6 start-page: 441 year: 2010 ident: CR67 article-title: Metabonomic, transcriptomic, and genomic variation of a population cohort publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2010.93 – volume: 43 start-page: 1575 year: 2011 end-page: 1581 ident: CR63 article-title: 2011 Compendium of physical activities: a second update of codes and MET values publication-title: Med. Sci. sports Exerc. doi: 10.1249/MSS.0b013e31821ece12 – volume: 26 start-page: 110 year: 2020 end-page: 117 ident: CR76 article-title: Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas publication-title: Nat. Med. doi: 10.1038/s41591-019-0722-x – volume: 7 start-page: 755 year: 2005 end-page: 761 ident: CR21 article-title: Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial publication-title: Diabetes, Obes. Metab. doi: 10.1111/j.1463-1326.2005.00468.x – volume: 368 start-page: 189 year: 1977 end-page: 194 ident: CR55 article-title: Effects of aldosterone on lipid metabolism and renal oxygen consumption in the rat publication-title: Pflug. Arch. doi: 10.1007/BF00585195 – volume: 282 start-page: 1568 year: 1999 end-page: 1575 ident: CR14 article-title: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.282.16.1568 – volume: 48 start-page: 1787 year: 1999 end-page: 1793 ident: CR43 article-title: Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion publication-title: Diabetes doi: 10.2337/diabetes.48.9.1787 – ident: CR77 – volume: 134 start-page: 1781 year: 2009 end-page: 1785 ident: CR66 article-title: High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism publication-title: Analyst doi: 10.1039/b910205a – volume: 110 start-page: 1093 year: 2002 end-page: 1103 ident: CR11 article-title: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency publication-title: J. Clin. Investig. doi: 10.1172/JCI0215693 – volume: 312 start-page: R938 year: 2017 end-page: R947 ident: CR39 article-title: Role of leptin in energy expenditure: the hypothalamic perspective publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00045.2016 – volume: 27 start-page: 1494 year: 2003 end-page: 1499 ident: CR22 article-title: Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. doi: 10.1038/sj.ijo.0802431 – volume: 39 start-page: 601 year: 2010 end-page: 605 ident: CR4 article-title: Effect of repeated fasting/refeeding on body weight control and energy balance regulation in rats publication-title: Wei Sheng Yan Jiu – volume: 98 start-page: E491 year: 2013 end-page: E496 ident: CR41 article-title: Experimental hyperleptinemia acutely increases vasoconstrictory sympathetic nerve activity in healthy humans publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2012-3009 – volume: 113 start-page: 400 year: 2019 end-page: 404 ident: CR57 article-title: Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment publication-title: Cytokine doi: 10.1016/j.cyto.2018.10.012 – volume: 10 year: 2019 ident: CR71 article-title: A comprehensive study of metabolite genetics reveals strong pleiotropy and heterogeneity across time and context publication-title: Nat. Commun. doi: 10.1038/s41467-019-12703-7 – volume: 1 start-page: 754 year: 2019 end-page: 764 ident: CR25 article-title: Leptin and the endocrine control of energy balance publication-title: Nat. Metab. doi: 10.1038/s42255-019-0095-y – volume: 41 start-page: 425 year: 2012 end-page: 443 ident: CR53 article-title: Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes publication-title: Endocrinol. Metab. Clin. North Am. doi: 10.1016/j.ecl.2012.04.017 – volume: 10 year: 2019 ident: CR72 article-title: A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals publication-title: Nat. Commun. doi: 10.1038/s41467-019-11311-9 – volume: 37 start-page: 936 year: 2001 end-page: 942 ident: CR40 article-title: Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure publication-title: Hypertension doi: 10.1161/01.HYP.37.3.936 – volume: 115 start-page: 3579 year: 2005 end-page: 3586 ident: CR47 article-title: Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight publication-title: J. Clin. Investig. doi: 10.1172/JCI25977 – volume: 382 start-page: 250 year: 1996 end-page: 252 ident: CR49 article-title: Role of leptin in the neuroendocrine response to fasting publication-title: Nature doi: 10.1038/382250a0 – volume: 11 year: 2020 ident: CR69 article-title: Heritability estimates for 361 blood metabolites across 40 genome-wide association studies publication-title: Nat. Commun. doi: 10.1038/s41467-019-13770-6 – volume: 66 start-page: 49 year: 2007 end-page: 57 ident: CR62 article-title: Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans publication-title: Clin. Endocrinol. – volume: 172 start-page: 234 year: 2018 end-page: 248 ident: CR35 article-title: Leptin mediates a glucose-fatty acid cycle to maintain glucose homeostasis in starvation publication-title: Cell doi: 10.1016/j.cell.2017.12.001 – volume: 91 start-page: 2605 year: 2006 end-page: 2611 ident: CR12 article-title: Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-1545 – volume: 971 start-page: 522 year: 2002 end-page: 527 ident: CR44 article-title: Regulation of catecholamine synthesis by leptin publication-title: Ann. N. Y Acad. Sci. doi: 10.1111/j.1749-6632.2002.tb04517.x – volume: 74 start-page: 426 year: 2001 end-page: 434 ident: CR60 article-title: Effects of weekly administration of pegylated recombinant human OB protein on appetite profile and energy metabolism in obese men publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/74.4.426 – volume: 11 year: 2020 ident: CR68 article-title: Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization publication-title: Nat. Commun. doi: 10.1038/s41467-019-13870-3 – volume: 3 start-page: 544 year: 1998 end-page: 547 ident: CR5 article-title: Leptin in relation to resumption of menses in women with anorexia nervosa publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4000418 – volume: 165 start-page: 249 year: 2011 end-page: 254 ident: CR17 article-title: Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-11-0252 – volume: 60 start-page: 1647 year: 2011 end-page: 1656 ident: CR16 article-title: Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance publication-title: Diabetes doi: 10.2337/db10-1791 – volume: 103 start-page: 8481 year: 2006 end-page: 8486 ident: CR27 article-title: Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0505429103 – volume: 128 start-page: 3237 year: 2018 end-page: 3239 ident: CR36 article-title: Physiological responses to leptin levels in lipodystrophy: a model for other hypoleptinemias? publication-title: J. Clin. Investig. doi: 10.1172/JCI122042 – volume: 65 start-page: 2179 year: 2016 end-page: 2186 ident: CR58 article-title: Leptin substitution in patients with lipodystrophy: neural correlates for long-term success in the normalization of eating behavior publication-title: Diabetes doi: 10.2337/db15-1550 – volume: 106 start-page: 13100 year: 2009 end-page: 13105 ident: CR7 article-title: Leptin-mediated changes in hepatic mitochondrial metabolism, structure, and protein levels publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0903723106 – volume: 163 start-page: 84 year: 2015 end-page: 94 ident: CR8 article-title: Sympathetic neuro-adipose connections mediate leptin-driven lipolysis publication-title: Cell doi: 10.1016/j.cell.2015.08.055 – volume: 34 start-page: 4313 year: 2018 end-page: 4314 ident: CR79 article-title: MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty528 – volume: 81 start-page: 3419 year: 1996 end-page: 3423 ident: CR3 article-title: Effect of fasting on serum leptin in normal human subjects publication-title: J. Clin. Endocrinol. Metab. – volume: 94 start-page: 8878 year: 1997 end-page: 8883 ident: CR9 article-title: Physiological response to long-term peripheral and central leptin infusion in lean and obese mice publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.94.16.8878 – volume: 26 start-page: 504 year: 2002 end-page: 509 ident: CR20 article-title: The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. doi: 10.1038/sj.ijo.0801952 – volume: 300 start-page: E392 year: 2011 end-page: E401 ident: CR42 article-title: Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00546.2010 – volume: 16 start-page: 109 year: 2003 end-page: 114 ident: CR18 article-title: Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans publication-title: Diabetes, Nutr. Metab. – volume: 268 start-page: 1578 year: 1992 end-page: 1580 ident: CR32 article-title: A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.1992.03490120092034 – volume: 47 start-page: 753 year: 2008 end-page: 764 ident: CR30 article-title: Pharmacokinetics of subcutaneous recombinant methionyl human leptin administration in healthy subjects in the fed and fasting states: regulation by gender and adiposity publication-title: Clin. Pharmacokinetics doi: 10.2165/00003088-200847110-00006 – volume: 269 start-page: 543 year: 1995 end-page: 546 ident: CR6 article-title: Weight-reducing effects of the plasma protein encoded by the obese gene publication-title: Science doi: 10.1126/science.7624777 – volume: 7 year: 2017 ident: CR33 article-title: Energy expenditure estimation from respiration variables publication-title: Sci. Rep. doi: 10.1038/s41598-017-16135-5 – volume: 95 start-page: 309 year: 2012 end-page: 317 ident: CR46 article-title: Leptin reverses declines in satiation in weight-reduced obese humans publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.111.012385 – volume: 17 start-page: 3291 year: 1999 end-page: 3298 ident: CR54 article-title: Dietary fat and carbohydrates are independently associated with circulating insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 concentrations in healthy adults publication-title: J. Clin. Oncol. doi: 10.1200/JCO.1999.17.10.3291 – volume: 60 start-page: 479 year: 2018 end-page: 489 ident: CR10 article-title: Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy publication-title: Endocrine doi: 10.1007/s12020-018-1589-1 – volume: 7 year: 2016 ident: CR73 article-title: Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA publication-title: Nat. Commun. doi: 10.1038/ncomms11122 – volume: 334 start-page: 292 year: 1996 end-page: 295 ident: CR2 article-title: Serum immunoreactive-leptin concentrations in normal-weight and obese humans publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199602013340503 – volume: 71 start-page: 620 year: 2018 end-page: 632 ident: CR74 article-title: Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.12.006 – volume: 67 start-page: 296 year: 2018 ident: CR23 article-title: Efficacy of metreleptin for weight loss in overweight and obese adults with low leptin levels publication-title: Diabetes doi: 10.2337/db18-296-LB – volume: 60 start-page: 1474 year: 2011 end-page: 1477 ident: CR15 article-title: Recombinant human leptin treatment does not improve insulin action in obese subjects with type 2 diabetes publication-title: Diabetes doi: 10.2337/db10-1302 – volume: 3 start-page: e121434 year: 2018 ident: CR34 article-title: The circulating metabolome of human starvation publication-title: JCI insight doi: 10.1172/jci.insight.121434 – volume: 64 start-page: 500 year: 2019 end-page: 511 ident: CR13 article-title: Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy publication-title: Endocrine doi: 10.1007/s12020-019-01862-8 – volume: 1 start-page: 1311 year: 1995 end-page: 1314 ident: CR1 article-title: Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action publication-title: Nat. Med. doi: 10.1038/nm1295-1311 – volume: 346 start-page: 570 year: 2002 end-page: 578 ident: CR31 article-title: Leptin-replacement therapy for lipodystrophy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa012437 – volume: 21 start-page: 951 year: 2013 end-page: 956 ident: CR45 article-title: Randomized double-blind placebo-controlled study of leptin administration after gastric bypass publication-title: Obesity doi: 10.1002/oby.20433 – volume: 302 start-page: 59 year: 2020 end-page: 61 ident: CR75 article-title: Reply to: “Methodological issues regarding: “a third of nonfasting plasma cholesterol is in remnant lipoproteins: lipoprotein subclass profiling in 9293 individuals”” publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.03.028 – volume: 5 year: 2015 ident: CR38 article-title: Intracerebroventricular administration of leptin increase physical activity but has no effect on thermogenesis in cold-acclimated rats publication-title: Sci. Rep. doi: 10.1038/srep11189 – volume: 33 start-page: 1871 year: 1992 end-page: 1876 ident: CR78 article-title: Rapid separation of serum lipids for fatty acid analysis by a single aminopropyl column publication-title: J. Lipid Res. – volume: 272 start-page: R1204 year: 1997 end-page: R1209 ident: CR50 article-title: Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice publication-title: Am. J. Physiol. – volume: 26 start-page: 24 year: 2017 end-page: 26 ident: CR24 article-title: Leptin’s physiologic role: does the emperor of energy balance have no clothes? publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.05.013 – volume: 118 start-page: 2583 year: 2008 end-page: 2591 ident: CR48 article-title: Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli publication-title: J. Clin. Investig. – volume: 108 start-page: 6585 year: 2011 end-page: 6590 ident: CR28 article-title: Leptin is an effective treatment for hypothalamic amenorrhea publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015674108 – volume: 401 start-page: 73 year: 1999 end-page: 76 ident: CR56 article-title: Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy publication-title: Nature doi: 10.1038/43448 – volume: 99 start-page: E2529 year: 2014 end-page: E2538 ident: CR59 article-title: Leptin therapy alters appetite and neural responses to food stimuli in brain areas of leptin-sensitive subjects without altering brain structure publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2014-2774 – volume: 95 start-page: 309 year: 2012 ident: 18885_CR46 publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.111.012385 – volume: 1 start-page: 1311 year: 1995 ident: 18885_CR1 publication-title: Nat. Med. doi: 10.1038/nm1295-1311 – volume: 163 start-page: 84 year: 2015 ident: 18885_CR8 publication-title: Cell doi: 10.1016/j.cell.2015.08.055 – volume: 269 start-page: 540 year: 1995 ident: 18885_CR37 publication-title: Science doi: 10.1126/science.7624776 – volume: 134 start-page: 1781 year: 2009 ident: 18885_CR66 publication-title: Analyst doi: 10.1039/b910205a – volume: 60 start-page: 479 year: 2018 ident: 18885_CR10 publication-title: Endocrine doi: 10.1007/s12020-018-1589-1 – volume: 268 start-page: 1578 year: 1992 ident: 18885_CR32 publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.1992.03490120092034 – volume: 71 start-page: 620 year: 2018 ident: 18885_CR74 publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.12.006 – volume: 7 start-page: 755 year: 2005 ident: 18885_CR21 publication-title: Diabetes, Obes. Metab. doi: 10.1111/j.1463-1326.2005.00468.x – volume: 47 start-page: 753 year: 2008 ident: 18885_CR30 publication-title: Clin. Pharmacokinetics doi: 10.2165/00003088-200847110-00006 – volume: 25 start-page: 507 year: 2019 ident: 18885_CR61 publication-title: Nat. Med. doi: 10.1038/s41591-019-0370-1 – volume: 110 start-page: 1093 year: 2002 ident: 18885_CR11 publication-title: J. Clin. Investig. doi: 10.1172/JCI0215693 – volume: 971 start-page: 522 year: 2002 ident: 18885_CR44 publication-title: Ann. N. Y Acad. Sci. doi: 10.1111/j.1749-6632.2002.tb04517.x – volume: 334 start-page: 292 year: 1996 ident: 18885_CR2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199602013340503 – volume: 81 start-page: 3419 year: 1996 ident: 18885_CR3 publication-title: J. Clin. Endocrinol. Metab. – volume: 27 start-page: 1494 year: 2003 ident: 18885_CR22 publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. doi: 10.1038/sj.ijo.0802431 – volume: 5 year: 2015 ident: 18885_CR38 publication-title: Sci. Rep. doi: 10.1038/srep11189 – volume: 10 year: 2019 ident: 18885_CR71 publication-title: Nat. Commun. doi: 10.1038/s41467-019-12703-7 – volume: 26 start-page: 24 year: 2017 ident: 18885_CR24 publication-title: Cell Metab. doi: 10.1016/j.cmet.2017.05.013 – volume: 272 start-page: R1204 year: 1997 ident: 18885_CR50 publication-title: Am. J. Physiol. – volume: 10 year: 2019 ident: 18885_CR70 publication-title: Nat. Commun. doi: 10.1038/s41467-019-13721-1 – volume: 10 year: 2019 ident: 18885_CR72 publication-title: Nat. Commun. doi: 10.1038/s41467-019-11311-9 – volume: 3 start-page: 544 year: 1998 ident: 18885_CR5 publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4000418 – volume: 3 start-page: 211 year: 2007 ident: 18885_CR64 publication-title: Metabolomics doi: 10.1007/s11306-007-0082-2 – volume: 103 start-page: 8481 year: 2006 ident: 18885_CR27 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0505429103 – volume: 172 start-page: 234 year: 2018 ident: 18885_CR35 publication-title: Cell doi: 10.1016/j.cell.2017.12.001 – volume: 26 start-page: 110 year: 2020 ident: 18885_CR76 publication-title: Nat. Med. doi: 10.1038/s41591-019-0722-x – volume: 16 start-page: 109 year: 2003 ident: 18885_CR18 publication-title: Diabetes, Nutr. Metab. – volume: 26 start-page: 504 year: 2002 ident: 18885_CR20 publication-title: Int. J. Obes. Relat. Metab. Disord.: J. Int. Assoc. Study Obes. doi: 10.1038/sj.ijo.0801952 – volume: 302 start-page: 59 year: 2020 ident: 18885_CR75 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2020.03.028 – ident: 18885_CR77 doi: 10.1101/2020.07.02.20143685 – volume: 91 start-page: 2605 year: 2006 ident: 18885_CR12 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-1545 – volume: 115 start-page: 3579 year: 2005 ident: 18885_CR47 publication-title: J. Clin. Investig. doi: 10.1172/JCI25977 – volume: 368 start-page: 189 year: 1977 ident: 18885_CR55 publication-title: Pflug. Arch. doi: 10.1007/BF00585195 – volume: 60 start-page: 1474 year: 2011 ident: 18885_CR15 publication-title: Diabetes doi: 10.2337/db10-1302 – volume: 66 start-page: 49 year: 2007 ident: 18885_CR62 publication-title: Clin. Endocrinol. doi: 10.1111/j.1365-2265.2006.02684.x – volume: 351 start-page: 987 year: 2004 ident: 18885_CR29 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa040388 – volume: 11 year: 2020 ident: 18885_CR68 publication-title: Nat. Commun. doi: 10.1038/s41467-019-13870-3 – volume: 85 start-page: 4003 year: 2000 ident: 18885_CR19 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.85.11.6955 – volume: 300 start-page: E392 year: 2011 ident: 18885_CR42 publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00546.2010 – volume: 17 start-page: 3291 year: 1999 ident: 18885_CR54 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.1999.17.10.3291 – volume: 41 start-page: 425 year: 2012 ident: 18885_CR53 publication-title: Endocrinol. Metab. Clin. North Am. doi: 10.1016/j.ecl.2012.04.017 – volume: 64 start-page: 500 year: 2019 ident: 18885_CR13 publication-title: Endocrine doi: 10.1007/s12020-019-01862-8 – volume: 3 start-page: e121434 year: 2018 ident: 18885_CR34 publication-title: JCI insight doi: 10.1172/jci.insight.121434 – volume: 33 start-page: 1871 year: 1992 ident: 18885_CR78 publication-title: J. Lipid Res. doi: 10.1016/S0022-2275(20)41345-8 – volume: 401 start-page: 73 year: 1999 ident: 18885_CR56 publication-title: Nature doi: 10.1038/43448 – volume: 65 start-page: 2179 year: 2016 ident: 18885_CR58 publication-title: Diabetes doi: 10.2337/db15-1550 – volume: 111 start-page: 1409 year: 2003 ident: 18885_CR26 publication-title: J. Clin. Investig. doi: 10.1172/JCI200317490 – volume: 106 start-page: 13100 year: 2009 ident: 18885_CR7 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0903723106 – volume: 67 start-page: 296 year: 2018 ident: 18885_CR23 publication-title: Diabetes doi: 10.2337/db18-296-LB – volume: 282 start-page: 1568 year: 1999 ident: 18885_CR14 publication-title: J. Am. Med. Assoc. doi: 10.1001/jama.282.16.1568 – volume: 6 start-page: 441 year: 2010 ident: 18885_CR67 publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2010.93 – volume: 48 start-page: 1787 year: 1999 ident: 18885_CR43 publication-title: Diabetes doi: 10.2337/diabetes.48.9.1787 – volume: 21 start-page: 951 year: 2013 ident: 18885_CR45 publication-title: Obesity doi: 10.1002/oby.20433 – volume: 60 start-page: 1647 year: 2011 ident: 18885_CR16 publication-title: Diabetes doi: 10.2337/db10-1791 – volume: 7 year: 2017 ident: 18885_CR33 publication-title: Sci. Rep. doi: 10.1038/s41598-017-16135-5 – volume: 37 start-page: 936 year: 2001 ident: 18885_CR40 publication-title: Hypertension doi: 10.1161/01.HYP.37.3.936 – volume: 94 start-page: 8878 year: 1997 ident: 18885_CR9 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.94.16.8878 – volume: 165 start-page: 249 year: 2011 ident: 18885_CR17 publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-11-0252 – volume: 113 start-page: 400 year: 2019 ident: 18885_CR57 publication-title: Cytokine doi: 10.1016/j.cyto.2018.10.012 – volume: 39 start-page: 601 year: 2010 ident: 18885_CR4 publication-title: Wei Sheng Yan Jiu – volume: 8 start-page: 192 year: 2015 ident: 18885_CR65 publication-title: Circ. Cardiovasc. Genet. doi: 10.1161/CIRCGENETICS.114.000216 – volume: 34 start-page: 4313 year: 2018 ident: 18885_CR79 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bty528 – volume: 108 start-page: 6585 year: 2011 ident: 18885_CR28 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015674108 – volume: 7 year: 2016 ident: 18885_CR73 publication-title: Nat. Commun. doi: 10.1038/ncomms11122 – volume: 269 start-page: 543 year: 1995 ident: 18885_CR6 publication-title: Science doi: 10.1126/science.7624777 – volume: 312 start-page: R938 year: 2017 ident: 18885_CR39 publication-title: Am. J. Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00045.2016 – ident: 18885_CR51 doi: 10.1210/clinem/dgaa251 – volume: 128 start-page: 3237 year: 2018 ident: 18885_CR36 publication-title: J. Clin. Investig. doi: 10.1172/JCI122042 – volume: 118 start-page: 2583 year: 2008 ident: 18885_CR48 publication-title: J. Clin. Investig. – volume: 382 start-page: 250 year: 1996 ident: 18885_CR49 publication-title: Nature doi: 10.1038/382250a0 – volume: 43 start-page: 1575 year: 2011 ident: 18885_CR63 publication-title: Med. Sci. sports Exerc. doi: 10.1249/MSS.0b013e31821ece12 – volume: 98 start-page: E491 year: 2013 ident: 18885_CR41 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2012-3009 – volume: 4 start-page: bvz022 year: 2020 ident: 18885_CR52 publication-title: J. Endocr. Soc. doi: 10.1210/jendso/bvz022 – volume: 99 start-page: E2529 year: 2014 ident: 18885_CR59 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2014-2774 – volume: 1 start-page: 754 year: 2019 ident: 18885_CR25 publication-title: Nat. Metab. doi: 10.1038/s42255-019-0095-y – volume: 346 start-page: 570 year: 2002 ident: 18885_CR31 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa012437 – volume: 74 start-page: 426 year: 2001 ident: 18885_CR60 publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/74.4.426 – volume: 11 year: 2020 ident: 18885_CR69 publication-title: Nat. Commun. doi: 10.1038/s41467-019-13770-6 |
SSID | ssj0000391844 |
Score | 2.5551672 |
Snippet | Based on studies in mice, leptin was expected to decrease body weight in obese individuals. However, the majority of the obese are hyperleptinemic and do not... Leptin treatment is effective to reduce body weight in animal models, but patients with obesity and associated hyperleptinemia do not respond well to leptin... |
SourceID | doaj pubmedcentral proquest crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 5145 |
SubjectTerms | 631/443/319 692/163/2743 82/16 82/58 Humanities and Social Sciences multidisciplinary Science Science (multidisciplinary) |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NS8MwFA8yELyInzi_iOBNi20-1vSo4hiinjbwFtImweHMZG0P_ve-pN1YPehF6Kl9oc3LS97v9X0hdAkazmhmeZTohEdMGAbn4CCLAIpzQb3Oin2i8PPLYDRhj6_8da3Vl48Ja8oDN4y7EaBhhAYDLi9AtSuft6k5MzG1xCRUhTRf0HlrxlQ4g2kGpgtrs2RiKm5KFs4Eby0lYPXxKOtoolCwv4Myf8ZI_nCUBv0z3EHbLXDEt80H76IN4_bQZtNK8msfjZ98eIrDwftdYhNS-vDUVerdYOU0tqrCH4CUcV5X2M2rJYkv8e_d1vXCADmeGeVwWef-90x5gCbDh_H9KGo7JkQFE1kVAThJrfa5q6kFQ0pZrlVqs9Ry4KECsERzmoNSTjkvMjswqSbWxolS1FASA3Q5RD03d-bIhzyxnGcFU4woZglTROhEpDrWhjEuTB8lS-7Joi0n7rtazGRwa1MhG45L4LgMHJdZH12txnw2xTR-pb7zi7Ki9IWwww0QD9mKh_xLPProYrmkEjaO94YoZ-Z1KYmvzEYB7pA-Sjtr3Xlj94mbvoUS3MBAAJYw8nopFbLd--UvMzr-jxmdoC0SpBgueop61aI2ZwCMqvw87IFv_akGWw priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature HAS Fully OA dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS-QwEA-ecnAvh1-H66lEuDct1-Zjmz6u4iKL-nIK-xbSJjkXNSu2-3D__c1k24WKLAh9aie0nUwyv2RmfiHkF3g4Z4WXSWYzmQjlBMyDwyIBKC4VR5-VYqHw7d3w-kFMpnK6QVhXCxOT9iOlZZymu-yw37WIQxoXOxks2mRSfCFbSNUOtr01Gk3-TFY7K8h5roRoK2RSrj5o3PNCkay_hzDf50e-C5JG3zPeJt9b0EhHy8_cIRsu7JKvy2Mk_-2R-xtMTQk0Rr5r6mI5H52Fxjw5aoKl3jT0BVAyLRcNDfOmE0F6fwxZgx5AnD47E2i9KHFrpt4nD-Or-8vrpD0tIamEKpoEgEnuLdat5h4WUcZLa3Jf5F5KZQ0AJV7yEhxyLmVV-KHLLfM-zYzhjrMUYMsPshnmwR1gupMoZVEJI5gRngnDlM1UblPrhJDKDUjWaU9XLZU4nmjxrGNImyu91LgGjeuocV0MyNmqzeuSSGOt9AV2ykoSSbDjjfnbX90ahVYAPpSFtX1ZAeozWNJrpXAp98xl3KgBOe26VMOgwUiICW6-qDVDVjYOUIcNSN7r694b-0_C7DHSb4MCAVRCy_POKnQ77us1f3T4OfGf5BuL9goXPyKbzdvCHQP8acqT1t7_A97s_hU priority: 102 providerName: Springer Nature |
Title | Leptin alters energy intake and fat mass but not energy expenditure in lean subjects |
URI | https://link.springer.com/article/10.1038/s41467-020-18885-9 https://www.proquest.com/docview/2451131292 https://pubmed.ncbi.nlm.nih.gov/PMC7553922 https://doaj.org/article/84158d742bc143a7890d54e03f2e13a8 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3ra9swEBd9MNiX0b1Y9gga7NvmzdYjkj-MkYZmJaxlbA3km5AtaStNlS22of3vd5LtgkspA2ODffLjpPP9Tqe7Q-gdaDhrmONJZjKeMGkZ_AcneQJQnEsadFYaAoVPTifHS7ZY8dUO6ssddQys7jTtQj2p5Xb98erv9RcQ-M9tyLj8VLEo7sEQysCg40m-i_ZBM4lQ0eCkg_vxz0xzMGiCo5mkLEuAgHZxNHffZqCrYkr_AQ69vYrylis1aqj5AXrUQUs8bcfCY7Rj_RP0oC02ef0UnX0LC1g8jv7xCtsY9IfPfa0vLNbeYKdrfAlYGhdNjf2m7klCEYDg2G62Fsjx2mqPq6YIEzjVM7ScH53NjpOupkJSMpnXCcAX4UyIbhUOTC3tuNHC5cJxLo0GOEULWoDaFpyXuZtYYYhzaaY1tZSkAG6eoz2_8fZFWBTFCp6XTDOimSNME2kyKUxqLGNc2hHKeu6psks4HuperFV0fFOpWo4r4LiKHFf5CL2_afOnTbdxL_Vh6JQbypAqO57YbH-pTvKUBIgijWCkKAEb6hD4azizKXXEZlTLEXrbd6kC0Qr-Eu3tpqkUCbnbKAAiMkJi0NeDJw6v-PPfMUk3MBCgJ7T80I8K1Q_ue77o5X-8zCv0kMRBCht9jfbqbWPfADKqizHaFSsBezn_Okb70-ni5wKOh0en33_A2dlkNo5zDuMoFv8AxZkMtA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VIgSXqrzEUgpG4gYRiR-Jc4QV1QLbnrZSb5YT27SieFGTPfDvmfEmK6VClZBySsZKMh57PntmPgO8Qw_nnQwqK1yhMqm9xHmwrDOE4koL8lk5FQqfnpWLc_ntQl3sAR9rYVLSfqK0TNP0mB32sZNpSNNip8BFm8rqe3AfsXZJljwv57t9FWI811IO9TG50P9oOvFBiap_gi9vZ0feCpEmz3NyCAcDZGSfth_5GPZ8fAIPtodI_nkKqyUlpkSW4t4d86mYj13F3v70zEbHgu3ZL8TIrNn0LK77UYTI_SlgjVpAcXbtbWTdpqGNme4ZnJ98Wc0X2XBWQtZKXfcZwpIqOKparQIuoWxQzlahroJS2lmESaIRDbrjSqm2DqWvHA8hL6wVXvAcQctz2I_r6F9QspNsVN1KK7mVgUvLtSt05XLnpVTaz6AYtWfagUiczrO4NimgLbTZatygxk3SuKln8H7X5veWRuNO6c_UKTtJosBON9Y3P8xgEkYj9NAOV_ZNi5jPUkGvU9LnInBfCKtn8HbsUoNDhuIgNvr1pjOcONkEAh0-g2rS15M3Tp_Eq8tEvo0KREiJLT-MVmGGUd_d8Ucv_0_8DTxcrE6XZvn17PsRPOLJdvESr2C_v9n4YwRCffM6Wf5fuf__qQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB6VrUBcEE-x5WUkbhBI7PHGOS6PVVlKhUQr9WY5sV0qWm_VZA_8e8beZKVUqBJSTsk4j7Gd-cYz8xngDVk4Z9HLrLCFzFA5pP_grMoIikslos3KY6Hw98PZ_jEuT-TJDsyGWpiUtJ8oLdNvesgO-9BimtLR2SnIaZNZ9f7S-luwS3i7wAnszufLn8vt6krkPVeIfZVMLtQ_bjCyRImwf4Qyr-dIXguUJvuzuA_3euDI5ptXfQA7LjyE25utJP88gqODmJ4SWIp-t8ylkj52Fjrz2zETLPOmYxeElFm97lhYdYNIpPiPYWvSBYmzc2cCa9d1XJ5pH8Px4svRp_2s3zEha1BVXUbgpPQ21q6Wnhwp46U1pa9KL6WyhsCSqEVNRrmUsqn8zJWWe58XxggneE7Q5QlMwiq4pzHlCWtZNWiQG_QcDVe2UKXNrUOUyk2hGLSnm55OPO5qca5TWFsovdG4Jo3rpHFdTeHtts3lhkzjRumPsVO2kpEIO51YXZ3qfmBoRQBEWfLv64aQn4llvVaiy4XnrhBGTeH10KWaJk6MhpjgVutW88jMJgju8CmUo74ePXF8JZz9ShTcpEACltTy3TAqdD_32xu-aO__xF_BnR-fF_rg6-G3Z3CXp6FLh3gOk-5q7V4QGurql_3Q_wuiVAIc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leptin+alters+energy+intake+and+fat+mass+but+not+energy+expenditure+in+lean+subjects&rft.jtitle=Nature+communications&rft.au=Chrysafi%2C+Pavlina&rft.au=Perakakis%2C+Nikolaos&rft.au=Farr%2C+Olivia+M&rft.au=Stefanakis%2C+Konstantinos&rft.date=2020-10-13&rft.issn=2041-1723&rft.eissn=2041-1723&rft.volume=11&rft.issue=1&rft.spage=5145&rft_id=info:doi/10.1038%2Fs41467-020-18885-9&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |